Quick Answer
LB PHARMACEUTICALS INC reported Net Income of -$25.20 million for fiscal year 2025.
LB PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$25.20M | +60.1% |
| 2024 | -$63.10M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.56M | +74.9% | +27.0% |
| June 30, 2025 | -$4.87M | +82.4% | +8.2% |
| March 31, 2025 | -$5.31M | +67.3% | +62.6% |
| September 30, 2024 | -$14.18M | — | +48.7% |
| June 30, 2024 | -$27.63M | — | -70.4% |
| March 31, 2024 | -$16.22M | — | — |
- LB PHARMACEUTICALS INC showed an increase of +60.1% in Net Income compared to the prior fiscal year.
- Over the 2024–2025 period, LB PHARMACEUTICALS INC’s net income has grown by 60.1% (from -$63.10 million to -$25.20 million).
- The most recent figure is from LB PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: